The Highlights of the 15th international conference of the international mesothelioma interest group – do molecular concepts challenge the traditional approach to pathological mesothelioma diagnosis?

The 15th and first virtual iMig meeting was held May 7-9, 2021 [1]. It was striking that nearly all of the speakers in the Pathology Session highlighted challenges pathologists currently face in mesothelioma diagnosis, with the focus of the presentations on ancillary techniques, which was only recently included in the WHO classification [2]. The present study summarizes the work presented by the different speakers of this session [3 –8]. The WHO excludes cytology samples from diagnosis of mesothelioma in situ, but cytology diagnosis of mesothelioma (usually in conjunction with clinical information) is provided in some centres, and pathologists with cytology practice are considering the implications.
Source: Lung Cancer - Category: Cancer & Oncology Authors: Tags: Review Source Type: research